Literature DB >> 19306916

Cell cycle dependent histone dynamics of an episomal non-viral vector.

Sina Rupprecht1, Hans J Lipps.   

Abstract

Non-viral episomal vectors are regarded as attractive alternatives to currently used virus-based vectors in gene therapy. In addition, they represent a minimal model system to study the epigenetic control of basic nuclear processes, such as transcription, replication and nuclear retention. Here we analyze the dynamics of histone modifications during the cell cycle of the episomally replicating vector pEPI-eGFP. The histone code of pEPI-eGFP was compared to its integrating counterpart pGFP-C1. We found that pEPI-eGFP is preferentially associated with histone modifications typical for active chromatin, while pGFP-C1 is mostly decorated with repressive histone modifications. During interphase the distribution of histone modification on pEPI-eGFP is very non-dynamic; the S/MAR shows the highest concentration of active histone modifications. However, they are specifically removed during mitosis and this may correlate with the association and co-segregation of pEPI with the host chromosomes during cell division.

Mesh:

Substances:

Year:  2009        PMID: 19306916     DOI: 10.1016/j.gene.2009.03.010

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  10 in total

Review 1.  Nanoparticles for retinal gene therapy.

Authors:  Shannon M Conley; Muna I Naash
Journal:  Prog Retin Eye Res       Date:  2010-05-07       Impact factor: 21.198

2.  Differential chromatin structure encompassing replication origins in transformed and normal cells.

Authors:  Domenic Di Paola; Emmanouil Rampakakis; Man Kid Chan; Maria Zannis-Hadjopoulos
Journal:  Genes Cancer       Date:  2012-02

3.  Long-term episomal transgene expression from mitotically stable integration-deficient lentiviral vectors.

Authors:  Hanna Kymäläinen; J Uwe Appelt; Frank A Giordano; Angela F Davies; Caroline M Ogilvie; Sherif G Ahmed; Stephanie Laufs; Manfred Schmidt; Juergen Bode; Rafael J Yáñez-Muñoz; George Dickson
Journal:  Hum Gene Ther       Date:  2014-04-10       Impact factor: 5.695

Review 4.  Nanoparticle-based technologies for retinal gene therapy.

Authors:  Jeffrey Adijanto; Muna I Naash
Journal:  Eur J Pharm Biopharm       Date:  2015-01-12       Impact factor: 5.571

5.  Stable S/MAR-based episomal vectors are regulated at the chromatin level.

Authors:  Federico Tessadori; Kang Zeng; Erik Manders; Martijn Riool; Dean Jackson; Roel van Driel
Journal:  Chromosome Res       Date:  2010-11-16       Impact factor: 5.239

6.  S/MAR-containing DNA nanoparticles promote persistent RPE gene expression and improvement in RPE65-associated LCA.

Authors:  Adarsha Koirala; Rasha S Makkia; Shannon M Conley; Mark J Cooper; Muna I Naash
Journal:  Hum Mol Genet       Date:  2013-01-18       Impact factor: 6.150

7.  Genomic cis-acting Sequences Improve Expression and Establishment of a Nonviral Vector.

Authors:  Claudia Hagedorn; Michael N Antoniou; Hans J Lipps
Journal:  Mol Ther Nucleic Acids       Date:  2013-09-03       Impact factor: 10.183

8.  Genome-wide profiling of S/MAR-based replicon contact sites.

Authors:  Claudia Hagedorn; Andreas Gogol-Döring; Sabrina Schreiber; Jörg T Epplen; Hans J Lipps
Journal:  Nucleic Acids Res       Date:  2017-07-27       Impact factor: 16.971

9.  Generation of a tumor- and tissue-specific episomal non-viral vector system.

Authors:  Rudolf Haase; Terese Magnusson; Baowei Su; Florian Kopp; Ernst Wagner; Hans Lipps; Armin Baiker; Manfred Ogris
Journal:  BMC Biotechnol       Date:  2013-06-04       Impact factor: 2.563

10.  Advances in the Development and the Applications of Nonviral, Episomal Vectors for Gene Therapy.

Authors:  Grace Elizabeth Mulia; Virginia Picanço-Castro; Eleana F Stavrou; Aglaia Athanassiadou; Marxa Leão Figueiredo
Journal:  Hum Gene Ther       Date:  2021-09-20       Impact factor: 5.695

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.